Literature DB >> 22842304

Schistosoma mansoni schistosomula tegument (Smteg) immunization in absence of adjuvant induce IL-10 production by CD4+ cells and failed to protect mice against challenge infection.

Juliano Michel Araujo1, Tatiane Teixeira de Melo, Isabela Campos de Sena, Clarice Carvalho Alves, Neusa Araujo, Fernanda do Valle Durães, Sergio Costa Oliveira, Cristina Toscano Fonseca.   

Abstract

The Schistosoma mansoni tegument interaction with the immune system plays a key role in disease establishment or elimination. We have recently demonstrated that S. mansoni schistosomula tegument (Smteg) is able to activate innate immune response and to induce protective immunity in a vaccine formulation with Freunds adjuvant. In this work, we evaluated the ability of Smteg to elicit protection in the absence of adjuvant. Smteg mice immunization resulted in significant antibody production, increased percentage of CD4+IFN-g+ and CD4+IL-10+ cells in spleen and increased production of IFN-g and IL-10 by spleen cells, but failed to reduce parasite burden, female fecundity and morbidity. We also demonstrated that BMDC stimulation with Smteg resulted in significant IL-10 production. Our results demonstrate that Smteg has immune modulatory proprieties.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842304     DOI: 10.1016/j.actatropica.2012.07.007

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  7 in total

1.  Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel.

Authors:  Edward Yepes; Rubén E Varela-M; Julio López-Abán; Jose Rojas-Caraballo; Antonio Muro; Faustino Mollinedo
Journal:  PLoS Negl Trop Dis       Date:  2015-07-20

2.  Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan Motifs.

Authors:  Cornelis H Smit; Angela van Diepen; D Linh Nguyen; Manfred Wuhrer; Karl F Hoffmann; André M Deelder; Cornelis H Hokke
Journal:  Mol Cell Proteomics       Date:  2015-04-16       Impact factor: 5.911

3.  Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.

Authors:  Clarice Carvalho Alves; Neusa Araujo; Viviane Cristina Fernandes dos Santos; Flávia Bubula Couto; Natan R G Assis; Suellen B Morais; Sérgio Costa Oliveira; Cristina Toscano Fonseca
Journal:  PLoS Negl Trop Dis       Date:  2015-02-27

Review 4.  Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

Authors:  Rachel Stephenson; Hong You; Donald P McManus; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2014-09-02

5.  Schistosoma mansoni Tegument (Smteg) Induces IL-10 and Modulates Experimental Airway Inflammation.

Authors:  Fábio Vitarelli Marinho; Clarice Carvalho Alves; Sara C de Souza; Cintia M G da Silva; Geovanni D Cassali; Sergio C Oliveira; Lucila G G Pacifico; Cristina T Fonseca
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

6.  Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice.

Authors:  Suellen B Morais; Barbara C Figueiredo; Natan R G Assis; Jane Homan; Fábio S Mambelli; Rodrigo M Bicalho; Cláudia Souza; Vicente P Martins; Carina S Pinheiro; Sergio C Oliveira
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

7.  Immune Dysfunction and Coinfection with Human Immunodeficiency Virus and Schistosoma japonicum in Yi People.

Authors:  Yu Yang; Peng-Lei Xiao; Ya Yang; Jian-Chuan Gao; Yan Shi; Wan-Ting Cheng; Yue Chen; Xiu-Xia Song; Qing-Wu Jiang; Yi-Biao Zhou
Journal:  J Immunol Res       Date:  2018-07-02       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.